For this reason, delanzomib may be available for the treatment of some systemic autoimmune diseases including RA, psoriasis vulgaris, atopic dermatitis, and so on, where TNF-α plays an important role in the pathophysiology. The gene discussed is TNF; the disease is atopic eczema.